Skip to main content
. Author manuscript; available in PMC: 2022 Jun 19.
Published in final edited form as: Semin Ophthalmol. 2021 May 23;37(2):136–141. doi: 10.1080/08820538.2021.1929347

Table 2. Comparison of Baseline Characteristics between non proliferative and proliferative MacTel.

Baseline characteristic Non proliferative MacTel Patients (Eyes) Proliferative MacTel Patients (Eyes) P value Total Patients (Eyes)
Participants 43 (67 eyes) 13 (15 eyes) 47 (82 eyes)
Mean age in years ± SD 55.98 ± 8.02 55.54 ± 6.27 0.86 55.87±7.87
Male: female 21: 24 7: 6 0.89 22 :25
Median visual acuity log MAR (IQR,Q1-Q3) 0.2 (IQR,0.1-0.3) 0.5 (IQR,0.25-0.7) 0.009 0.3 (IQR,0.1-0.5)
Diabetes mellitus (%) 25 (58.14%) 10 (76.92%) 0.33 27 (57.45%)
Median duration of DM (IQR,Q1-Q3) 7.5 (IQR,3-15) years 4.5 (IQR,3-7) years 0.35 7 years (IQR,3-14.75)
Hypertension (HT) 22 (51.16%) 7 (53.85%) 0.89 23 (48.94%)
Median duration of HT(IQR,Q1-Q3) 6 years (IQR,3-15) 7.5 (IQR,3.5-13.75) years 0.85 6 years (IQR,3-15)